Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

By Andrew Silver SHANGHAI (Reuters) -Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

A review of the front page stories from the daily newspapers in Scotland.

Lizzo shed light on her go-to meals that have helped her maintain her weight loss goals amid her health journey.

Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Focusing solely on achieving weight loss for people with a high body mass index (BMI) may do more harm than good, argue ...